Recent studies implicate altered immune response as an overlapping phenotype between PAH-patient-derived cells and a mouse KCNK3 knockout model, suggesting that alterations in immune cells may underlie susceptibility to PAH in patients with KCNK3 mutation [37]. The gene discussed is KCNK3; the disease is pulmonary arterial hypertension.